The role of plasma aminothiols in the prediction of coronary microvascular dysfunction and plaque vulnerability

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 266-272

  Dhawan, Saurabh S ^a   Eshtehardi, Parham ^a   McDaniel, Michael C ^a   Fike, Lucy V ^a   Jones, Dean P ^a   Quyyumi, Arshed A ^a   Samady, Habib ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary flow reserve; Coronary microvascular function; Cystine glutathione ratio; Glutathione; Hs CRP; Hyperemic microvascular resistance; Intravascular ultrasound; Plaque necrotic core

Indexed keywords

AMINOTHIOL; C REACTIVE PROTEIN; CYSTINE; GLUTATHIONE;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; CORONARY VASCULAR RESISTANCE; EPICARDIUM; FEMALE; HEART CATHETERIZATION; HUMAN; HYPEREMIA; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE;

AGED; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; CYSTEINE; CYSTINE; FEMALE; GLUTATHIONE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERICARDIUM; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS;

EID: 80054993906     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.020     Document Type: Article

References (30)

1. Camici P.G., Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
2. Pepine C.J., Anderson R.D., Sharaf B.L., Reis S.E., Smith K.M., Handberg E.M., Johnson B.D., Sopko G., Bairey Merz C.N. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol 2010, 55:2825-2832.
3. Chamuleau S.A.J., Tio R.A., de Cock C.C., de Muinck E.D., Pijls N.H.J., van Eck-Smit B.L.F., et al. Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease. J Am Coll Cardiol 2002, 39:852-858.
4. Sicari R., Rigo F., Cortigiani L., Gherardi S., Galderisi M., Picano E. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 2009, 103:626-631.
5. Stone G.W. Providing regional observations to study predictors of events in the coronary tree (PROSPECT). Transcatheter Cardiovascular Therapeutics 2009.
6. Jones D.P. Redefining oxidative stress. Antioxid Redox Signal 2006, 8:1865-1879.
7. Ashfaq S., Abramson J.L., Jones D.P., Rhodes S.D., Weintraub W.S., Hooper W.C., et al. Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension 2008, 52:80.
8. Ashfaq S., Abramson J.L., Jones D.P., Rhodes S.D., Weintraub W.S., Hooper W.C., et al. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 2006, 47:1005-1011.
9. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109. II-2-10.
10. Pijls N., de Bruyne B., Peels K., van der Voort P., Bonnier H., Bartunek J., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996, 334:1703-1708.
11. Gould K., Kirkeeide R., Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990, 15:459-474.
12. Meuwissen M., Chamuleau S.A.J., Siebes M., Schotborgh C.E., Koch K.T., de Winter R.J., et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 2001, 103:184-187.
13. Kern M., Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol 2010, 55:173-185.
14. Mintz G., Nissen S., Anderson W., Bailey S., Erbel R., Fitzgerald P., et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents developed in col laboration with the European society of cardiology endorsed by the society of cardiac angiography and interventions. J Am Coll Cardiol 2001, 37:1478-1492.
15. Jones D.P., Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 2009, 47:1329-1338.
16. Dade-Behring, Behring nephelometer instruction manual, Deerfield, IL; 1999.
17. Griendling K., FitzGerald G. Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003, 108:1912-1916.
18. Ursini F., Maiorino M., Brigelius-Flohe R., Aumann K., Roveri A., Schomburg D., et al. Diversity of glutathione peroxidases. Methods Enzymol 1995, 252:38-53.
19. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999, 31:273-300.
20. Kevelaitis E., Nyborg N.C.B., Menasché P. Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage. Transplantation 1997, 64:660-663.
21. Lapenna D., de Gioia S., Ciofani G., Mezzetti A., Ucchino S., Calafiore A., et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998, 97:1930-1934.
22. Jones D.P., Go Y.-M., Anderson C.L., Ziegler T.R., Kinkade J.J.M., Kirlin W.G. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 2004.
23. Go Y.-M., Jones D.P. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation 2005, 111:2973-2980.
24. Kaufmann P.A., Gnecchi-Ruscone T., di Terlizzi M., Schafers K.P., Luscher T.F., Camici P.G. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000, 102:1233-1238.
25. Andrews N.P., Prasad A., Quyyumi A.A. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001, 37:117-123.
26. Prasad A., Andrews N.P., Padder F.A., Husain M., Quyyumi A.A. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. J Am Coll Cardiol 1999, 34:507-514.
27. Marroquin O., Kip K., Mulukutla S., Ridker P., Pepine C., Tjandrawan T., et al. Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. Am Heart J 2005, 150:109-115.
28. Nakamura T, Kubo N., Funayama H., Sugawara Y., Ako J., Momomura S.-i. Plaque characteristics of the coronary segment proximal to the culprit lesion in stable and unstable patients. Clin Cardiol 2009, 32:E9-E12.
29. Nair A., Kuban B., Tuzcu E., Schoenhagen P., Nissen S., Vince D. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002, 106:2200.
30. Nasu K., Tsuchikane E., Katoh O., Vince D., Virmani R., Surmely J., et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006, 47:2405.